Tumor markers in gynaecology
differences between HE4, CA125, and ROMA values and sensitivity, PPV,... | Download Scientific Diagram
ROMA, an algorithm for ovarian cancer - ScienceDirect
Contribution of ROMA index towards the primar diagnosis of ovarian cancer
Role of HE4 and ROMA Score in Diagnosis of Ovarian Cancer in Egyptian Women | Semantic Scholar
Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis | Scientific Reports
Comparison of Risk of Ovarian Malignancy Algorithm and cancer antigen 125 to discriminate between benign ovarian tumor and early‑stage ovarian cancer according to imaging tumor subtypes
Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models with clinical-ultrasonographic feature for diagnosing ovarian neoplasms
Patient risk classification using CA125, HE4 and ROMA predictive model. | Download Table
Diagnostic performance of CA125, HE4, ROMA, and CPH‐I in identifying primary ovarian cancer - Luo - 2023 - Journal of Obstetrics and Gynaecology Research - Wiley Online Library
RMI and ROMA are equally effective in discriminating between benign and malignant gynecological tumors: A prospective population‐based study - Liest - 2019 - Acta Obstetricia et Gynecologica Scandinavica - Wiley Online Library
Modified HE4, CA125, and ROMA cut-off values and predicted probability of ovarian tumor in Chinese patients - Zhao - Gland Surgery
Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer | Scientific Reports
Ultrasound-based radiomics for predicting different pathological subtypes of epithelial ovarian cancer before surgery | BMC Medical Imaging | Full Text
What's new in biomarker testing for ovarian cancer
JPM | Free Full-Text | Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature
ROMA (Risk of Ovarian Malignancy Algorithm)
Evaluation in the predictive value of serum human epididymal protein 4 (HE4), cancer antigen 125 (CA 125) and a combination of both in detecting ovarian malignancy
ROMA (Risk of Ovarian Malignancy Algorithm)
ROMA Cost in Delhi Test Price Near Me, India | GDIC
C- 1 A New Test for Assessing the Risk of Ovarian Cancer in Women with Adnexal Mass Presenter Place Date. - ppt download
KoreaMed Synapse
Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis | Scientific Reports
Cancers | Free Full-Text | The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population
SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian
What's new in biomarker testing for ovarian cancer
ROMA (Risk of Ovarian Malignancy Algorithm)
